Spanien - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

virbac - leptospira interrogans, serovariedad canicola, inactivada, cepa 601903 - suspensiÓn inyectable - leptospira interrogans, serovariedad canicola, inactivada, cepa 601903 4350 - leptospira - perros

Venezuela - spansk - Instituto Nacional de Higiene

calox international, c.a. - vacuna inactivada adsorbida contra la hepattis a - suspension inyectable - 80 u

Den Europæiske Union - spansk - EMA (European Medicines Agency)

zoetis belgium sa - circovirus porcino vacuna inactivada, recombinante) - immunologicals for suidae, inactivated viral vaccines - los cerdos (de engorde) - para la inmunización activa de cerdos desde las 3 semanas de edad contra el circovirus porcino tipo 2 (pcv2) para reducir la carga viral en sangre y tejidos linfoides y la excreción fecal causada por la infección con pcv2.

Spanien - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

merck sharp & dohme animal health s.l. - salmonela enteritidis subsp enteritidis inactivada cepa pt4 - suspensiÓn inyectable - salmonela enteritidis subsp enteritidis inactivada cepa pt4 1 - salmonella - gallinas ponedoras; pollos reproductores

Spanien - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

merck sharp & dohme animal health s.l. - lawsonia intracellularis, inactivada, cepa spah-08 - liofilizado y disolvente para emulsion para inyeccion - lawsonia intracellularis, inactivada, cepa spah-08 5323 - lawsonia - porcino

Den Europæiske Union - spansk - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - cerdos - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Venezuela - spansk - Instituto Nacional de Higiene

sanofi-aventis de venezuela, s.a. - vacuna contra hepatitis a inactivada - suspension inyectable - 80u/0.5ml(a7)-a

Venezuela - spansk - Instituto Nacional de Higiene

espromed bio, c.a. - vacuna contra la influenza fraccionada inactivada - solucion - 15 µg ha

Venezuela - spansk - Instituto Nacional de Higiene

aventis pharma s.a. - difterica tetanica,pertusica y poliomelitica inactivada - suspension inyectable - 0,5 ml (a1)

Venezuela - spansk - Instituto Nacional de Higiene

empresa socialista para la produccion de medicamentos biologicos espromed bio, c.a. - vacuna contra la influenza inactivada fraccionada - suspension inyectable